TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
Business Of Biotech
00:00
Transplanting T Cells to Prevent Relapse
We have this very elegant approach in how we treat and, and there may be one or two others who are in this space, but they all, everyone does it differently. As far as, as based on what's called a CD 34 selected transplant. So, so an unrelated donor, donates blood cells. And then we separate those stem cells from the T cells. We save the stem cells to give as part of the transplant. Then we take the T cells and it's T cells we just talked about, right, that we need for the anti leukemia effect.
Transcript
Play full episode
